Compare CTMX & PRPL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CTMX | PRPL |
|---|---|---|
| Founded | 2008 | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Home Furnishings |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 596.2M | 76.9M |
| IPO Year | 2015 | N/A |
| Metric | CTMX | PRPL |
|---|---|---|
| Price | $4.30 | $0.70 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 6 | 1 |
| Target Price | ★ $6.50 | $1.00 |
| AVG Volume (30 Days) | ★ 2.8M | 223.6K |
| Earning Date | 11-06-2025 | 11-04-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 50.22 | N/A |
| EPS | ★ 0.24 | N/A |
| Revenue | $113,631,000.00 | ★ $457,012,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $12.69 |
| P/E Ratio | $17.28 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.40 | $0.56 |
| 52 Week High | $4.66 | $1.29 |
| Indicator | CTMX | PRPL |
|---|---|---|
| Relative Strength Index (RSI) | 56.60 | 43.48 |
| Support Level | $3.98 | $0.70 |
| Resistance Level | $4.66 | $0.75 |
| Average True Range (ATR) | 0.29 | 0.04 |
| MACD | -0.01 | -0.00 |
| Stochastic Oscillator | 54.04 | 24.67 |
CytomX Therapeutics Inc a clinical-stage, oncology-focused biopharmaceutical company developing novel, masked, conditionally activated biologics designed to be localized to the tumor microenvironment. It is engaged in developing antibody therapeutics based on probody technology platforms. The company's probody technology platform creates proprietary cancer immunotherapies against clinically-validated targets and develops cancer therapeutics. Probody therapeutics are designed to take advantage of conditions in the tumor microenvironment to enhance the tumor-targeting features of an antibody and reduce drug activity in healthy tissues.
Purple Innovation Inc is a comfort innovation company. The company designs, manufactures and sells a range of comfort technology offerings, including mattresses, a pillow, cushions, sheets, bed platforms and other products. The Company has one reportable segment that operates an omni-channel distribution which allows the Company to offer a seamless shopping experience to its customers across multiple sales channels. It sells its products through its direct-to-consumer e-commerce channels, retail brick-and-mortar wholesale partners, Purple showrooms, and third-party online retailers.